Interaksi Metiltestosteron

These drugs include, but are not limited to, the following: the anticonvulsants carbamazepine, oxcarbazepine, phenobarbital, phenytoin the androgen receptor inhibitor enzalutamide the antimycobacterials rifampin, rifapentine the cytotoxic agent mitotane St. (label Doravirin, Kontraindikasi)

Because of the ability of Type II 5α-reductase inhibitors to inhibit the conversion of testosterone to 5α-dihydrotestosterone (DHT), finasteride may cause abnormalities of the external genitalia of a male fetus of a pregnant female who receives finasteride. (label Finasterid, Kontraindikasi)

CONTRAINDICATIONS: Precocious puberty, prostatic carcinoma or other androgen-dependent neoplasm, prior allergic reaction to HCG. (label Gonadotropin korionik, Kontraindikasi)

To date, epidemiologic studies and randomized controlled trials have been inconclusive for determining the risk of major adverse cardiovascular events (MACE), such as non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death, with the use of testosterone compared to non-use. (label Metiltestosteron, Peringatan)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (label Metiltestosteron, Interaksi obat)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (label Metiltestosteron, Interaksi obat)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (label Metiltestosteron, Interaksi obat)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (label Metiltestosteron, Interaksi obat)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (label Metiltestosteron, Interaksi obat)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (label Metiltestosteron, Interaksi obat)

Free hormone concentrations, such as testosterone and estradiol, may be decreased. (label Estradiol dan noretisteron, Peringatan dan perhatian)

Free hormone concentrations, such as testosterone and estradiol, may be decreased. (label Estrogen terkonjugasi, Perhatian)

Free hormone concentrations, such as testosterone and estradiol, may be decreased. (label Estrogen terkonjugasi dan bazedoksifen, Peringatan dan perhatian)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

For Men : Clinical monitoring for spermatogenesis utilizes the following indirect or direct measures: Serum testosterone level Semen analysis 5.11 FOLLISTIM Pen The FOLLISTIM Pen is intended only for use with FOLLISTIM AQ Cartridge. (label Folitropin, Peringatan dan perhatian)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (label Metiltestosteron, Interaksi obat)

…medications, pramlintide acetate, insulin, angiotensin converting enzyme (ACE) inhibitors, H 2 receptor antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs… (label Glimepirid, Interaksi obat)

Effect on QT/QTc Interval: Androgen deprivation therapy may prolong the QT interval. (label Goserelin, Peringatan dan perhatian)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (label Metiltestosteron, Interaksi obat)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (label Metiltestosteron, Interaksi obat)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (label Metiltestosteron, Interaksi obat)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (label Metiltestosteron, Interaksi obat)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (label Metiltestosteron, Interaksi obat)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (label Metiltestosteron, Interaksi obat)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (label Metiltestosteron, Interaksi obat)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

PRECAUTIONS General Induction of androgen secretion by hCG may cause fluid retention. (label Koriogonadotropin alfa, Perhatian)

Tumor Flare: Increased serum testosterone (~ 50% above baseline) may occur when initiating treatment with LUPRON DEPOT. (label Leuprorelin, Peringatan dan perhatian)

Androgens/Anabolic Steroids Asparaginase Glucocorticoids Slow-Release Nictonic Acid These drugs may decrease serum TBG concentration. (label Levotiroksin, Interaksi obat)

Androgens/Anabolic Steroids Asparaginase Glucocorticoids Slow-Release Nicotinic Acid These drugs may decrease serum TBG concentration. (label Liotironin, Interaksi obat)

However, clinical studies have shown that lovastatin does not reduce basal plasma cortisol concentration or impair adrenal reserve, and does not reduce basal plasma testosterone concentration. (label Lovastatin, Interaksi obat)

The following laboratory tests may be affected by progestins including MPA Injectable Suspension, USP: (a) Plasma and urinary steroid levels are decreased (e.g., progesterone, estradiol, pregnanediol, testosterone, cortisol). (label Medroksiprogesteron, Interaksi obat)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

…anti-diabetic medications, pramlintide acetate, insulin, angiotensin converting enzyme (ACE) inhibitors, H2 receptor antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs… (label Pioglitazon dan glimepirid, Interaksi obat)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Reproductive effects: Include decreased testosterone and increased prolactin levels. (label Ramelteon, Peringatan dan perhatian)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (label Metiltestosteron, Interaksi obat)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Abiraterone: Spironolactone binds to the androgen receptor and may increase prostate‑specific antigen (PSA) levels in abiraterone-treated prostate cancer patients. (label Spironolakton dan hidroklorotiazid, Interaksi obat)

Hypercalcemia in Patients with Metastatic Breast Cancer As with other additive hormonal therapy (estrogens and androgens), hypercalcemia has been reported in some breast cancer patients with bone metastases within a few weeks of starting treatment with tamoxifen. (label Tamoksifen, Peringatan dan perhatian)

Insulin: In diabetic patients the metabolic effects of androgens may decrease blood glucose and insulin requirements. (label Metiltestosteron, Interaksi obat)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (label Metiltestosteron, Peringatan)

Tumor Flare: Transient increase in serum testosterone levels can occur within the first few weeks of treatment. (label Triptorelin, Peringatan dan perhatian)

DRUG INTERACTIONS Anticoagulants: C-17 substituted derivatives of testosterone, such as methandrostenolone, have been reported to decrease the anticoagulant requirements of patients receiving oral anticoagulants. (label Metiltestosteron, Interaksi obat)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (label Metiltestosteron, Perhatian)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (label Metiltestosteron, Perhatian)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (label Metiltestosteron, Perhatian)

Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. (label Metiltestosteron, Perhatian)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)